IMR Press / EJGO / Volume 32 / Issue 2 / pii/1630979923861-995137999

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Original Research
Prognosis and role of postmastectomy radiotherapy in patients with T1-T2 breast cancer with one to three positive axillary nodes
Show Less
1 Department of Radiotherapy, Tianjin Cancer Institute and Hospital; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education; Key Laboratory of Cancer Prevention and Therapy, Tianjin
2 Department of Radiotherapy, Shandong Cancer Institute and Hospital, Jinan (China)
Eur. J. Gynaecol. Oncol. 2011, 32(2), 141–145;
Published: 10 April 2011

Purpose: To evaluate the prognosis and role of postmastectomy radiotherapy (PMRT) in T1-T2 breast cancer with one to three positive axillary nodes. Methods: The 10-year Kaplan-Meier locoregional recurrence (LRR), distant recurrence (DR), disease-free survival (DFS) and overall survival (OS) were compared between the N0 and 1-3N+ cohorts. The role of PMRT was evaluated in the 1-3N+ cohort. Results: The 10-year LRR, DR, DFS, OS rates in N0 and the 1-3N+ cohorts were as follows: LRR 7.5% vs 19.4% (p = 0.011); DR 14.4% vs 23.0% (p = 0.029); DFS 71.3% vs 51.2% (p = 0.001) and OS 77.0% vs 58.7% (p = 0.001). Of the 192 1- 3N+ patients not treated and treated with PMRT, the outcomes were: LRR 20.1% vs 18.4% (p = 0.047); DR 26.4% vs 21.5% (p = 0.743); DFS 40.2% vs 55.4% (p = 0.260) and OS 40.7% vs 66.0% (p = 0.344), respectively. Conclusion: PMRT reduces the 10-year LRR rate for such patients, but further examination is needed.
Postmastectomy radiotherapy
Breast cancer
Positive axillary nodes
Back to top